[Serial tests of serum-digitoxin levels during digitoxin treatment (author's transl)].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000937:Antigen-Antibody Reactions; D001835:Body Weight; D009202:Cardiomyopathies / Q000188:drug therapy / Q000378:metabolism; D003404:Creatinine / Q000097:blood; D004074:Digitoxin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity; D006801:Humans; D007106:Immune Sera; D007676:Kidney Failure, Chronic / Q000378:metabolism; D008722:Methods; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000378:metabolism; D011863:Radioimmunoassay; D012709:Serum Albumin / Q000032:analysis
D007106:Immune Sera; D012709:Serum Albumin; D003404:Creatinine; D004074:Digitoxin
Therapie mit Digitoxin unter Kontrolle des Serum-Digitoxinspiegels